⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSNL News
Personalis, Inc. Common Stock
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits
businesswire.com
PSNL
Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium
businesswire.com
PSNL
Form 8-K
sec.gov
PSNL
Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring
businesswire.com
PSNL
Personalis to Participate in Upcoming Investor Events
businesswire.com
PSNL
Form 8-K
sec.gov
PSNL
Form 8-K
sec.gov
PSNL
Form 8-K
sec.gov
PSNL
Personalis Reports First Quarter Results and Recent Highlights
businesswire.com
PSNL
Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
businesswire.com
PSNL